ViaDerma, Inc. engages with the manufacturing and sales of pharmaceutical related products. The company is headquartered in Las Vegas, Nevada. The company went IPO on 2008-06-10. The Company’s lead product is a topical antibiotic, which is focused on being sold under the brand name Vitastem. The firm also has products in development in the fields: anti-aging skin care, pain management, hair-loss, and toenail fungus. The products are based on a patent pending delivery system technology that allows for rapid mass transfer of the pharmaceutical active ingredient across the skin and into the body to provide immediate localized therapy. The firm utilizes a specific trade secret formulation system in the manufacture of all products. The Company’s products are sold to local medical practitioners and patients in clinics primarily in the Los Angeles, California area. The Company’s subsidiary is ViaDerma, II Inc.
Follow-Up Questions
Viaderma Inc (VDRM)의 PER은 얼마입니까?
Viaderma Inc의 PER은 0.0924입니다
Viaderma Inc의 CEO는 누구입니까?
Rui Sheng Liu은 2009부터 회사에 합류한 Viaderma Inc의 President입니다.
VDRM 주식의 가격 성능은 어떻습니까?
VDRM의 현재 가격은 $0.0002이며, 전 거래일에 decreased 0% 하였습니다.
Viaderma Inc의 주요 사업 주제나 업종은 무엇입니까?
Viaderma Inc은 Pharmaceuticals 업종에 속하며, 해당 부문은 Health Care입니다
